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ABSTRACT 
In this study, multiple models from Atmospheric Chemistry and Climate Model 
Intercomparison Project (ACCMIP) are utilized to derive the global burden of disease of 
chronic obstructive pulmonary disease (COPD), lung cancer (LNC), and lower 
respiratory infection (LRI) derived from surface PM2.5 elevation. Various Representative 
Concentration Pathways and Shared Socio-economic Pathways scenarios are 
compared as well as various models to deduct the impact from various scenarios. The 
time series variation and seasonal variation are also illustrated in this study. Multi-model 
ensemble was conducted to reduce the deviation in model projection output. 
Projection shows increase in the population normalized relative risk for COPD, LNC, 
and LRI disease between 2030 and 2000 for developed countries and northern Africa 
for various population scenarios using the average value for different emission 
scenarios from GISS-E2-R model output. MIROC-CHEM actually predicts a much lower 
normalized PM concentration or relative risk level than GISS-E2-R model.  Black carbon 
adjusted relative risk results show that LNC derived relative risk might be much more 
sensitive for black carbon compared with COPD or LRI.  LAC region is more sensitive to 
black carbon surface pollution compared with other regions for LRI relative risk. 
Dust storms in the Saharan regions can be a major contribution to risk elevation in 
Saharan and adjacent regions. Australia dust storm in the central Australia can also be 
responsible to the exposure at coastal areas.  The emission increase in East Asia since 
1980s can be responsible to the widespread risk elevation in recent years.  
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CHAPTER ONE 
INTRODUCTION AND GENERAL INFORMATION 
1.1 PM2.5 POLLUTION DEFINITION 
PM2.5 is defined as air pollutants with a diameter of 2.5 micrometers or less. The small 
sizes makes PM2.5 penetrable and able to invade even the smallest airways of 
respiratory systems so as to cause related health impact among human beings.  
The ground level PM2.5 concentration has increased since preindustrial times along with 
the severity of PM2.5 pollution in the current era due to the anthological emissions 
associated with population growth and excessive emission from human activities. 
1.3 PM2.5 AND ITS RELATED HEALTH IMPACT 
In recent years, PM2.5 has been found to be associated with a large variety of health 
problems including premature mortality. EPA standards suggest that PM2.5 should be 
controlled under 12 𝜇𝑔/𝑚3 annually and 35 𝜇𝑔/𝑚3 daily to avoid adverse health impact. 
However, adverse health impact has been found to be associated with fine particulate 
pollution even with pollution level lower than the EPA suggestion level. (Shi et al., 2015) 
PM2.5 has been found to be linked to 3.3 million annual premature mortality over a global 
range in 2010. (Lelieveld et. al., 2015)  
In our study, the global burden of disease (GBD) assessment is applied to address the 
premature mortality derived from global PM2.5 model data and the adverse health impact 
is assumed to be only associated with the mass concentration of PM2.5 as source effect 
is not considered. Such assumptions can be seen as plausible for GBD studies as in 
Burnett’s study, the mass concentration is the main factor taken into consideration. To 
further address such problems, the black carbon (BC) data might be regarded as an 
additional indicator of health impact to adjust the toxicity of fine particles according to 
Janssen’s study. (Janssen et al., 2011)  
Primarily short term health impact is vastly examined and discussed from case studies 
or cohort studies. Linkage between PM2.5 exposure and acute diseases is verified in 
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many studies. For example, Ischemic heart disease (IHD) was found to be associated 
with short-term exposure to fine particulates. (Pope et al., 2006) BenMAP-CE is a tool 
developed and promoted by US-EPA to calculate the air pollution related acute health 
impact over the terrain of US and China by selected C-R functions from various 
references.   
Compared with PM10(particles with diameter smaller than 10 micrometer) or TSP(total 
suspend particle), PM2.5 is a good indicator of health impact since the fine particles are 
more penetrable to lung cells and enter bloodstreams compared with coarser particles. 
In a cohort study in Shanghai, particles with diameter ranging from 2.5 to 10 µm, health 
impact is attenuated and less precise while PM2.5 is statistically significant in adverse 
health impact. (Kan et al., 2007) 
1.4CLIMATE CHANGE AND EMISSION RELATED PM2.5 CAUSED 
HEALTH IMPACT 
The severity of PM2.5 in current years has been recognized and emphasized by multiple 
studies and with interests in addressing the future PM2.5 induced adverse health impact, 
especially premature mortality, to examine how far climate change alone would bring us 
regarding this problem.  
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) 
utilizes the new observation added to atmospheric chemistry to optimize the simulations 
of tropospheric ozone and aerosols. The modeled data from ACCMIP is used to 
calculate the PM2.5 mass concentration derived relative risk and premature mortality 
from pre-industrial time to the future era.  
1.41ACCMIP MODELS 
GFDL-AM3 is utilized to examine the PM2.5 concentration related health impact from 
1850 to 2000 in Fang’s study and it is found that the PM2.5 concentration change during 
industrial period is mainly caused by changes in direct emission. (Fang et. al., 2013)  
GISS-E2-R is utilized to analyze the future PM2.5 variation compared with baseline 
including pre-industrial time and present day in the Beijing-Tianjin-Hebei (Jing-Jin-Ji) 
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area with four different emission scenarios. (Jie et. al., 2016)  Among ACCMIP models, 
NCAR-CAM5.1 and GISS-E2-R-TOMAS have the most extensive description of 
aerosols compared with other models that can be used in this study.  GISS-E2-R 
includes the data from 1850 to 2100 for each year, so it is the most continuous data 
from the model in ACCMIP. This advantage helps to assist in the studies of Jing-jin-ji 
area concentration projection. 
The number of aerosol particle as well as the mass of each component are represented 
by internally-mixed log-normal modes in NCAR- CAM5.1.  While aerosol is represented 
by 108 size-resolved aerosol tracers plus three bulk aerosol-phase tracers in 12-size 
bins ranging from 10nm to 10µm in dry diameter in GISS-E2-R.  The LMDzORINCA 
model simulates the distribution of aerosols by superposition of log-normal modes. All 
other models use the bulk approach to calculate PM2.5. (Lamarque et al., 2013) 
 1.42 Chronic health impact  
Long-term exposure has also been proved to cause health impact when short-term 
health impact is excluded from a case study in the Schwartz’s study. (Schwartz, 2000)  
While most available health impact studies use short-term functions, it should be worth 
noticing that air pollution exposure can take effect after days.  A following-up cohort 
study suggests the association between chronic exposure and mortality rates for six 
cities over a 35 year range.(Lepeule et. al., 2012)  Chronic health impact is not 
researched enough in previous studies compared with acute health impact. However, 
chronic health impact has been associated with decreasing lung function in young 
adults. (Tager et al., 2005)  So it would be important to assess chronic health impact as 
well to add to the existing references. 
1.5 GLOBAL BURDEN OF DISEASE STUDIES 
Global burden of disease (GBD) was first launched by World Bank and World Health 
Organization in 1991 to close the gap between global challenges and lack of source 
information. The GBD study provides a systemic approach to appraise information for 
each condition in a critical way. (Murray et. al., 2013) Projection of future GBD is 
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projected from 1990 to 2020 in Murray’s study as to help with decision making. (Murray 
et. al., 1997)  GBD provides the information of the morbidity or mortality over a global 
range derived from air pollution so as to assess the impact over a global range. GBD 
results can also provide insight into specific regional problems by providing the spatial 
distribution of risk or mortality. Population distribution is considered as well as air 
pollution concentration in GBD assessment of outdoor premature mortality.(Brauer et 
al., 2012)  In conclusion, GDB studies can be helpful in decision making and there is still 
a lack of comprehensive air pollution derived premature mortality over a long time 
range. 
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CHAPTER TWO  
LITERATURE REVIEW 
 
Ambient fine particles (PM2.5), defined as particles less than 2.5 microns in aerodynamic 
diameter, is found to be associated with daily mortality and cardiovascular mortality from 
a study conducted in Shanghai. The compositions of PM2.5 include sulfate, nitrate, 
organic carbon, elemental carbon, dust and biological materials while PM10 is mainly 
composed of crustal material and primary organic materials. Although PM10 is also listed 
as a critical pollutant, the results of this study actually indicate that there is no significant 
association between PM10-2.5 and mortality. So it is logical and plausible to establish 
PM2.5 as an indicator of particle health impact. (Kan et al., 2007)  The starting 
concentration for the all six cities were less than 18 
𝜇𝑔
𝑚3
 and each increase of 10 in PM2.5 
is found to be associate with an increase of 14% in all-cause mortality, 26% in 
cardiovascular mortality and 37% in lung-cancer mortality. As concentration vary from 8 
to 15, the relation between chronic exposure to PM2.5 and all-cause, cardiovascular or 
lung-cancer mortality is found to be linear. (Lepeule et. al., 2012)  From the meta-
analysis results from short-term exposure to fine particulate matter, SO42-, NO3-, EC and 
OC are found to be positively associated with the increase in all cause, cardiovascular 
and respiratory mortality with carbon being most strongly associated. (1.3% per 𝜇g/m3) 
(Atkinson et. al., 2014) 
Anthological activities have influenced air pollution and related health impact since 
preindustrial times. This paper intends to look into the air pollution changes in the field 
of fine particulate matter, or more specifically PM2.5, since preindustrial times that can 
be attributed to anthological activities. Multiple models from the ACCMIP datasets are 
used for the results comparison.  Silvia’s paper looks into the global mortality changes 
due to ozone and fine particulate matter concentration changes attributed from both 
emission variation and climate change since preindustrial times.  Concentration is 
modeled by an ensemble of chemistry-climate models and Concentration response 
functions(CRFs) are selected from American Chemical Society(ACS) studies to 
calculate the global burden of disease distribution of air pollution related premature 
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death. The results indicate that there are 470,000 premature respiratory resulted from 
ozone and 2.1 million PM2.5 related cardiorespiratory disease (93%) and lung cancer 
(7%) mortality. It indicates that climate change might have little influence on global 
mortality.  Silvia’s study estimated the mortality at a higher accuracy using 1,850 air 
pollution modelling results instead of counterfactual low concentrations. But the CRFs 
might cause additional deviation or uncertainty compared with integrated risk functions 
when it comes to GBD calculation as the CRFs were originally used for America terrain.  
There is large variation among different models.  PM2.5 related mortality is widespread in 
heavily populated regions including East Asia, India, Southeast Asia, Europe and 
Former Soviet Union. One model (HadGEM2) estimates -283,000 deaths from PM2.5 
decreases from climate change while the whole 5 models estimate 2,200 climate 
change related mortality.  The multi-model median mortality is 61,000 annual deaths 
and would rise to 74,000 if HadGEM2 is excluded from the calculation. (Silva et al., 
2013) 
In Cohen’s study (Cohen et al., 2006), mortality from PM exposure was studied for all 
fourteen WHO regions with economic, meteorological and demographic data from 304 
cities in the year of 2000. Years lost is utilized to calculate the burden of disease from 
mortality from cardiopulmonary diseases and lung cancer in adults, together with acute 
respiratory infection of school children as the estimation is made based upon US cohort 
study derived risk coefficients.  It is assumed in the study that there is a linear 
association between death risk and PM2.5 mass concentration ranging from 7.5 to 
50𝜇g/m3.  Uncertainty might come from such assumption regarding both the response 
curve shape and counterfactual level.  For COPD, LC and ARI there are 3%, 5%, 1% 
mortality contribution over a global horizon and those three diseases contribute up to 
0.8 million premature death and 6.4 million years lost overall. The developing Asia takes 
up two thirds of the global burden of outdoor air pollution. Cohen’s study includes only 
urban area and excludes ozone impacts, thus might underestimating the PM2.5 health 
effect. 
In Anenberg’s paper (Anenberg et. al., 2010), long-term relative risk functions for ozone 
and PM2.5 from epidemiology literature are utilized to simulate concentration instead of 
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using measurement data. Measurement data may not include rural areas and 
assumptions may be required for background air pollution.  The results indicate that 
3.5±0.9 million cardiopulmonary and 220,000±80,000 lung cancer mortalities (30 ± 7.6 
million years of life lost) might be attributed to anthropogenic PM2.5 annually. Difference 
in methodology lead to 50% difference in PM2.5 mortality estimation compared with 
previous measurement derived results and that might be another reason why we should 
expand the simulation studies. Observations show that there is an increase of 
background concentration in remote regions since preindustrial times.  A global 
atmospheric chemical transport model is used to estimate mortality even for regions 
with sparse air quality measurements.  Anthropogenic air pollution is defined as the 
changes in pollution concentration between preindustrial and present levels.  The health 
impact functions assume that there is a log-linear relationship between relative risk (RR) 
and concentration. The RR function for PM2.5 is from Krewski’s study(Krewski et al., 
2009) with reanalysis of ACS studies.  MOZART-2 is used to simulate pollutant 
concentration with a resolution of 2.8° × 2.8°. PM2.5 is defined as SO4+NO3+BC+1.4*OC 
with the assumption of unchanged concentration of dust, sea salt and secondary 
organic aerosols.  
According to Pope’s study (Pope et al., 2011), for lung-cancer mortality there is a nearly 
linear association reaching RRs>40.  When PM2.5 concentration is low, cardiovascular 
disease accounts for higher proportion of mortality while lung cancer is more important 
when concentration is high.  In Apte’s study (Apte et. al., 2015), 10 km global data is 
used for pollutant concentration and IER functions developed for global burden of 
disease 2010 is utilized to estimate the attributable mortality effect from regional and 
global air quality improvement. In relatively clean regions, modest improvement would 
have large effect. While being in more polluted areas, major improvements would be 
required to substantially reduce PM2.5 derived mortality.  Five diseases including IHD, 
stroke, COPD, LC, ALRI account for 20.1 million deaths in 2010.  
In Wu’s paper (Wu et al., 2016), GISS-E2-R model was utilized for the relative change 
in PM2.5 concentration from preindustrial time to future era. The results indicate that for 
Jing-Jin-Ji area, which is located in China, will experience PM2.5 peak in 2020-2040.  J. 
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Lelieveld’s study (Lelieveld et. al., 2015) illustrates that the premature deaths derived 
from PM2.5 pollution is predominant in Asia, especially India and China. There is also an 
increasing trend of mortality as it would double by 2050 based on a business-as-usual 
emission scenario. In Lelieveld’s paper, a secondary analysis is conducted under the 
assumption that carbonaceous species are five times more toxic than crustal species, 
nitrate and sulfate.  For the reliability of SSP datasets, the analysis from Jiang’s 
research (Jiang, 2014) actually indicates that the interactions implied by the 
demographic assumptions in the SSPs fit the description from the literature results. 
Some inconsistency issues might come from inconsistent definitions of regions and 
limitations in the understanding of future interaction pattern changes through various 
socioeconomic development stages.  
IER model assumed that the toxicity of PM2.5 is only related to the mass exposure rather 
than composition. Such assumption might be a little bit too general as the composition 
of fine particle may vary greatly depending on different emission sources.  In the IER 
model, it is assumed that RRs are functions of PM2.5 mass concentration and are 
independent of component distribution. (Burnett et al., 2014a) PM toxicity might vary on 
account of composition. For example, carbonaceous specie has been shown to be more 
toxic and is assumed to be five times more toxic than inorganic components in 
Lelieveld’s paper. (Lelieveld et. al., 2015) 
In Janssen’s paper (Janssen et al., 2011) that was based on the meta-analysis of 34 
papers on time-series studies, the toxicity of black carbon particle was compared with 
PM2.5. The adverse mortality effect of black carbon particle is larger than PM2.5 alone. 
1𝜇g/m3 increase in PM2.5 is associated with 0.19% increase in all-cause mortality and 
0.29% increase in cardiovascular mortality. For EC, there is 1.45% increase in all-cause 
mortality and 1.77% increase in cardiovascular mortality.  From long-term exposure 
cohort studies, RR for EC is 7-16 times higher than that of PM2.5. There is 40%-70% EC 
in PM2.5 of roadside source.  
COPD is among the leading cause for global YLDs whether in 1990 and 2013. There is 
an increase of 96.4% of heart failure from 1990 to 2013 and one third of that is caused 
by ischaemic heart disease. (Bill et. al., 2015)  It is estimated that 89% of the worldwide 
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population has been exposed to PM2.5 contamination level that exceeds WHO air quality 
guidelines with annual average level 10 𝜇𝑔/𝑚3 while 32% of the global population are 
exposed to concentration exceeding 35 𝜇𝑔/𝑚3. It is estimated that 800,000 deaths and 
6.4 million lost years are attributed to fine particulate matter exposure in 2000. In 
Brauer’s study (Brauer et al., 2012), TM5 and satellite remote sensing data were 
averaged to indicate the concentration level over a global range. SAT approach, which 
measures the concentration level according to satellite observation of AOD, provides 
data even for regions without proper ground-level measurement data.  
One long-term Cohort study (Cao et al., 2011) in China indicate that there is significant 
association between air pollution and mortality from cardiopulmonary disease and lung 
cancer through proportional hazards regression model.  14 WHO regions in 2000 were 
investigated for economic, meteorological, demographic and PM data to estimate the 
burden of disease. PM2.5 concentration was achieved by PM10 concentration and 
available spatial distribution of PM2.5/PM10 ratio. It is assumed that there is linear 
correlation between PM2.5 concentration and risk within 7.5 and 50 𝜇𝑔/𝑚3.  PM2.5 
pollution is estimated to be responsible for 3% of adult cardiopulmonary mortality, 5% of 
trachea, bronchus, lung cancer mortality and 1% of acute respiratory disease derived 
mortality among children in the GBD analysis.  Developing countries contribute majorly 
to the global burden of disease while Asia specifically contributes two-thirds of the GBD. 
(Cohen et al., 2006) 
Asides from the probability of health impact from persistent exposure to high 
concentration of PM, it is also found that low concentration of PM may still pose as 
health risk regarding non-accidental and cardiovascular mortality. From the cohort study 
of Canadians, mortality is found to be associated with long-term PM2.5 exposure even at 
mean concentration of 8.7 𝜇𝑔/𝑚3 from the output of standard Cox models.(Crouse et 
al., 2012)  SeaWiFS and MIRS are combined with GEOS-Chem to derive the first global 
satellite PM2.5 estimate at a grid size of 10km*10km. There has been 0.55 
𝜇𝑔
𝑚3
/𝑦𝑒𝑎𝑟 
(2.1%/year) increase from 1998 to 2012 regarding global population weighted PM2.5 
concentration. (Donkelaar et. al., 2014) 
 
10 
 
CHAPTER THREE 
METHODOLOGY 
3.1 PARTICULATE CONCENTRATION  
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) 
includes a series of time slice experiments that are conducted to reveal the long-term 
changes in atmospheric composition and radiative forcing from preindustrial times to 
recent years and predict the effects further into the future. The time scale ranges from 
1850 to 2100. Among all the four RCP scenarios, RCP 6.0 includes short lived 
precursor emissions that are different from the others while RCP 2.6 and RCP 8.5 
provide the extremes in 2100 climate change or methane levels. The PM2.5 data are 
included in the following models: GISS-E2-R, GFDL-AM3, CICERO-OsloCTM2, NCAR-
CAM3.5, NCAR-CAM5.1, MIROC-CHEM, HadGEM2.(Lamarque et al., 2013) 
PM2.5 mass calculation for models without direct PM2.5 output is calculated using: 
PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust 
Gridded PM2.5 or components data are collected from different models and various 
sceneries as input. To facilitate the usage of population data and make different model 
comparable, model regrid was applied to original data converting the different gridded 
concentration data to the same grid (0.5°*0.5°). 
3.2 POPULATION DATASETS 
Population data for 1980-2100 was collected from the Center for global environmental 
research to calculate mortality. 
3.2.1 SSPs scenarios 
In the SSP1 scenario, the future is in a sustainable pathway with education and health 
investment. The population would be low and the human well-being is being heavily 
emphasized. SSP2 scenario assumes medium fertility with medium mortality, medium 
migration and medium education level while SSP3 refers to a world that population 
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growth is mainly in developing countries. SSP4 considers the future world of high 
inequalities. SSP5 indicates a world that emphasizes technological progress and 
economic growth. (KC et. al., 2014) 
3.2.2 The advantage of SSPs 
For climate change related research, the Shared Socio-economic Pathways (SSPs) has 
also been used as demographic data input. For example, in Lutz’s research, the 
variation in population size and structure were studied regarding the contribution 
towards greenhouse gas emission and capacity of adapting to climate change. IPCC-
SRES (Intergovernmental Panel on Climate Change—Special Report on Emissions 
Scenarios) scenarios only include trajectories for total population size, SSPs address 
the predicted trajectories for all age, sex and education details for all countries. (Lutz et. 
al., 2015)  When measuring the total mortality from IHD, the mortality distribution is 
closely associated with age. So more detailed prediction would be required to achieve 
the results.  
3.3 PM2.5 DERIVED RRS AND MORTALITY BASED UPON IER MODEL 
3.3.1 RRs value 
The IER functions developed by Burnett are used for assessing the global burden of 
disease is as below. 
For the calculation of relative risk value: 
For z< zcf, 
RRIER(z)=1 
When exposure level is lower than the threshold, there would be no additional health 
risk since RR=1 means the risk is exactly the baseline. 
For z≥ zcf, 
RRIER(z)=1+𝛼{1 − exp [−𝛾(𝑧 − zcf)
𝛿]} 
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For exposure larger than threshold value, relative risk is larger than 1 and the increase 
is determined by the difference between exposure level and threshold level, disease 
endpoint parameters (𝛼, 𝛾, 𝛿).  
Z-exposure to PM2.5 (𝑢𝑛𝑖𝑡: 𝜇𝑔/𝑚3) 
𝑧𝑐𝑓 − 𝑐𝑜𝑢𝑛𝑡𝑒𝑟𝑓𝑎𝑐𝑡𝑢𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑏𝑒𝑙𝑜𝑤 𝑤ℎ𝑖𝑐ℎ 𝑡ℎ𝑒𝑟𝑒 𝑖𝑠 𝑛𝑜 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑟𝑖𝑠𝑘 
The unknown parameter sets (𝛼, 𝛾, 𝛿) are estimated by nonlinear regression methods 
and there are different parameter values for various locations or diseases. The 
advantage of IER model compared with traditional concentration-response (CR) 
functions is that this model can be applied to global range analysis without causing too 
much uncertainty associated with the limitation of endpoints.(Burnett et al., 2014a)  The 
lookup table from Apte’s study (Apte et. al., 2015) was utilized to calculate the RRs for 
this study.  The three main chronic diseases related to PM2.5 concentration variation are 
COPD (chronic obstructive pulmonary disease), LNC (lung cancer), LRI (lower 
respiratory infection). It indicates that IER model is superior in predicting RR compared 
with seven other forms of models in previous references.  RR values were calculated 
with the IER model data of 1000 endpoints from apte’s research to generate the relative 
risk values for COPD, LRI, LNC, IHD that are associated with PM2.5 mass concentration 
variation from a time range of 1850 to 2100.  
3.3.2 Mortality value 
The mortality rate in each grid is calculated as below: 
𝑀𝑖,𝑗 = 𝑃𝑖 × 𝐼𝑗,𝑘 × (𝑅𝑅𝑗(𝐶𝑖) − 1) 
𝐼𝑗,𝑘 =
𝐼𝑗,𝑘
𝑅𝑅̅̅ ̅̅ 𝑗,𝑘
 
𝑃𝑖 − 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑟𝑖𝑑 𝑐𝑒𝑙𝑙 i 
𝐼𝑗,𝑘 − 𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 𝑟𝑒𝑔𝑖𝑜𝑛𝑎𝑙 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑎𝑛𝑛𝑢𝑎𝑙 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑟𝑎𝑡𝑒 𝑓𝑜𝑟 
 𝑒𝑛𝑑𝑝𝑜𝑖𝑛𝑡 𝑗 𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 𝑘 
𝐶𝑖 − 𝑎𝑛𝑛𝑢𝑎𝑙𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑃𝑀2.5 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑐𝑒𝑙𝑙 𝑖 
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𝑅𝑅𝑗(𝐶𝑖) − 𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑟𝑖𝑠𝑘 𝑓𝑜𝑟 𝑒𝑛𝑑𝑝𝑜𝑖𝑛𝑡 𝑗 𝑎𝑡 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝐶𝑖 
 
Population normalized RR value: 
𝑅𝑅̅̅ ̅̅ 𝑗,𝑘 =
∑ 𝑃𝑖 × 𝑅𝑅𝑗
𝑁
𝑖=1 (𝐶𝑖)
∑ 𝑃𝑖
𝑁
𝑖=1
 
Population normalization is useful in adjusting exposure level. For example, there is grid 
A and grid B with the same risk value derived from concentration and the population is 
100 in grid A while the population is 0 in grid B. The exposure in grid B would not add to 
the normalized value since no population means no exposure while grid A would add to 
the normalized value by the extent limited by population in grid A. This example 
illustrates that normalization is an effective way to measure human related exposure. 
Spatial distribution of PM2.5 concentration would be only relevant to the measurement 
when the population is not blank. Non-populated areas including oceans can be 
excluded from contributing to the exposure calculation while highly-populated areas 
would further add to calculation. 
The change in mortality: ∆𝑀𝑖,𝑗=𝑃𝑖 × 𝐼𝑗,𝑘 × (𝑅𝑅𝑗(𝐶𝑖
∗) − 𝑅𝑅𝑗(𝐶𝑖)) 
Since there might be multiple risk factors for point estimates, it is not accurate to 
describe the reduction in attributable mortality as “lives saved”. It can be regarded as 
the reduction of mortality statistically under certain scenario with given data and 
parameters. The result is statistically significant but may not be associated with one or 
two human being as speaking. The change in mortality between baseline situation and 
hypothetical situation would be an insight into policy making.  
The simplified mortality change function from Lelieveld’s paper (Lelieveld et al., 
2015)( ∆𝑀𝑜𝑟𝑡 = 𝑦0[(RR-1)/RR]Pop ) is applied to the calculation. 
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3.4 INTEGRATION AND COMPARISON 
3.4.1 The world regions and related integrated data 
UN divides the world into 10 regions in the UN Millenium Development Goals (MDG) 
regions according to development extent. The MDG regions include developed 
countries (DC), caucasus and central Asia (CIS), Northern Africa (NA), Latin America 
and the Carribbean (LAC), Eastern Asia (EA), Southern Asia (SA), South-eastern Asia 
(SEA), Western Asia (WA) and Oceania (O).1 The development extent of regions would 
be an important consideration since both population and anthological emission could be 
related to the development extent. Figure 1 is the UN division map. 
3.4.2 The reason for using three year average data 
For long-term climate change and pollution changes, one year data would be not 
sufficient enough to represent a decade. So for common long-term climate change or 
pollution variation studies, the way to represent decade data is to use multi-year 
average.  
3.4.3 Time series 
1850 is used to describe the air pollution related health impact in the past at the end of 
industrial evolution.  2000 is used to represent the current years.  2030 would be a good 
indicator for the sustainability achievements for the future.  It is predicted by UN that at 
the time of 2050, 70% of world population to be crammed into poor, overcrowded, 
polluted urban areas so the mortality variation based upon air pollution and population 
would be a major problem in the future.2 The year around 2050 should a good indicator 
of future scenarios.  
3.4.4 Comparison 
The output RRs and mortality are compared within different sceneries and models. 
Comparisons are also made between our study and other studies found in the literature. 
 
                                                          
1 http://mdgs.un.org/unsd/mdg/Host.aspx?Content=Data/RegionalGroupings.htm 
2 https://aftermathnews.wordpress.com/2010/03/24/un-by-2050-70-of-world-population-to-be-crammed-into-poor-overcrowded-
polluted-urban-corridors-comprising-a-tiny-fraction-of-habitable-land/ 
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Figure 1 UN regions3 
 
 
 
 
                                                          
3 http://nuclearsuntan.blogspot.com/2011/11/un-divides-world-into-10-regional.html 
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3.5 UNCERTAINTY MEASUREMENT 
3.5.1 Uncertainty in concentration data 
The variation in RRs and ∆𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 between various climate models and different 
sceneries are calculated for each spatial grid and each MDG region. For various 
radiative forcing scenarios, best scenario (RCP 2.6) with +2.6W/m2 increased forcing is 
theoretical quite different from the worst scenario (RCP 8.5) with +8.5W/m2. What effect 
would various scenarios cast upon the projection, the association between radiation 
forcing and near surface fine particle concentration and the possible future coming from 
worst scenario are taken into consideration when analyzing the problem.  RCP 2.6 and 
RCP 8.5 provide extremes in 2100 climate change and methane levels. RCP 6.0 is 
significantly different than the others since it contains very different short-lived precursor 
emissions. (Lamarque et al., 2013) 
Furthermore, various models depict the distribution differently due to the mechanism. 
Natural emission alone can cause the significant variation among models. NCAR-
CAM5.1 and GISS-E2-R describe aerosols in an extensive way. Representation of non- 
methane hydrocarbon chemistry varies among different models, which is responsible for 
different model performance. Aerosol in NCAR-CAM5.1 is represented by three 
internally-mixed log- normal modes (Aitken, accumulation, and coarse) while aerosol in 
GISS-E2-R is represented by 108 size-resolved aerosol tracers plus three bulk aerosol- 
phase tracers. LMDzORINCA model uses a modal approach to simulate the distribution 
of aerosols.  All other models use the bulk approach.  Models except GISS-E2-R 
includes limited heterogeneous reactions. Half of all ACCMIP models include the 
indirect effect of aerosols.  Since different models work differently, there is no way of 
assuming any model has the best prediction results. Some models do predict with 
higher sensitivity for certain regions. In atmospheric or climate change related modelling 
studies, multi-ensemble is used to increase projection accuracy. 
In Fowler’s study (Toggweiler et.al., 2001), multi-model ensemble is used to assess the 
precipitation extremes in UK. Ensemble generally increase the skill, reliability and 
consistency of predictions compared with single model so that it would be useful in 
lowering projection errors.  In climate models, the equally weighted average of several 
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models is usually found to agree better than any single models. In IPCC reports, 
unweighted multi-model means is usually used to present best guess projection instead 
of one model. (Tebaldi et. al., 2007)  Since it is complicated to determine the weight for 
each model, unweighted mean would be used in this study to output the ensemble 
results. 
3.5.2 Uncertainty in population data 
The variation of mortality caused by various sceneries of population (SSP1, SSP2, 
SSP3) is calculated for each grid and UN region. Since SSP1 represents the 
sustainable population pathway, SSP2 indicates intermediate challenges while SSP3 is 
the scenario of fragmentation, the projection of mortality and population normalized 
relative risk or PM2.5 concentration exposure can be varied due to the various 
assumptions of future population distribution and total number.  
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CHAPTER FOUR 
RESULTS 
4.1 SEASONAL DISTRIBUTION OF RRS FROM GISS-E2-R MODEL 
OUTPUT 
For relative risk values, the value 1 is regarded as baseline which means there is no 
additional health risk and the larger risk value indicates elevated risk. For example, in 
regions with risk of 2, the exposure health impact is twice of that of baseline or 
background.  So, if the population distribution does not change, the premature mortality 
caused by certain disease from time A should be twice of the mortality value from time 
B for the same region. Risk is an extent to which exposure might influence the 
population living in certain region, so population is a major factor in determining how 
influential it is of health relative risk. Population normalization and mortality is calculated 
to make such linkage. 
In some cases, a value slightly less than 1 was calculated due to the data processing. In 
these cases, it does not mean the risk is actually reduced since there is no way of 
having a risk value less than the background. Risk values less than 1 should be treated 
as 1 but such values does mean than the near surface concentration is so low 
compared with health impact function that no additional risk should be considered. 
Figure 2-3, 50-51, 52-53 depict the monthly relative risk for COPD, LNC, LRI 
respectively in 1850s from the data collected and averaged from GISS-E2-R model 
outputted PM2.5 concentration. 
Figures 54 - 59 depict the monthly relative risk for COPD, LNC, LRI respectively in 
1860s from the data collected and averaged from GISS-E2-R model outputted PM2.5 
concentration. 
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Figure 2 Global relative risk for cardiopulmonary disease from January to June of the three year average data from 
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 3 Global relative risk for cardiopulmonary disease from July to December  of the three year average data from 
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint.
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From the spatial distribution of relative risk for cardiopulmonary disease (RRCOPD) 
over the global terrain in pre-industrial times, it is observed that there is a widely 
distributed elevated RR value in September compared with previous month.  The peak 
value start to spread from northern Africa to Western Asia and southern Asia since May. 
The risk peak in Western and Southern Asia start to decrease since October.  Overall 
there is only a slight elevation of relative risk of COPD disease due to PM2.5 surface 
concentration while the highest peak exist in Africa regions. The RR value for the whole 
globe ranges from 1.02 to 1.7, which indicates that health risk is not elevated for the 
preindustrial times.  The relative risk of LNC ranges from to 2.05 with relatively lower 
concentration levels in February and July.  LRI disease risk is more varied compared 
with COPD and LNC.  There is a slight elevation in RR value for COPD in 1860s 
compared with 1850s with an increase from 1.7 to 2.24. 
LNC risk value is majorly elevated as the peak value has increased from 2.05 in 1850 to 
3.05 in 1860. The elevation indicates a major increase in fine particulate induced lower 
respiratory infection health risk in the pre-industrial times. The relative risk is overall low 
in August.  Such output means that for maximum exposure regions the risk for lung 
cancer due to air pollution has increased from twice the baseline to three times the 
baseline. 
Figure 60-61, 62-63, 64-65 describe the disease risk for COPD, LNC, LRI respectively 
in 2000s. Figure 66-67, 68-69, 70-71 depict the relative risk for COPD, LNC, LRI 
respectively in 2030s. Figure 4-5, 72-73, 74-75 depict the relative risk for COPD, LNC, 
LRI respectively in 2050s. 
The risk value is much elevated in eastern Asia in April and May, then it start to 
decrease in June and increase to a higher level again in August, September and 
October. The reason for such seasonal variation might be partially due to seasonal 
change in Asia dust storm.  
The RCP2.6 scenario actually assumes the best emission situation as the emission of 
all three major greenhouse gas species (CO2, CH4, N2O) are projected to keep 
decreasing since 2000s. The comparison between 1850s and 2050s (under RCP2.6 
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scenario) shows that there is not much difference between the seasonal distribution and 
overall risk elevation levels of preindustrial times and future era. 
It shows a widespread elevation in RR values all over the globe in April since 1900s.  
There is a lower level of RR distribution in May, Jun, July for future times compared with 
current years from the comparison of 1900s-2000s and 2030s-2050s.  
 
4.2 ANNUAL PLOT OF GISS-E2-R MODEL OUTPUT 
Figure 6-9 describe the annual relative risk of COPD endpoint plot from 1850s to 2090s 
from GISS-E2-R with RCP2.6 as the future emission scenario. 
The annual plot of COPD relative risk distribution from 1850 to 2090 shows that there 
are lower levels of COPD relative risk for the time of 1860s, 1910s, 1970s while there is 
a relatively high level in 1850s. COPD relative risk value varies from 1.02 to 1.58. The 
elevated value starts emerge in southern Asia since 1980s and emerge in south-eastern 
Asia since 2000s. The elevated level is projected to disappear since 2050s.   
The spatial distribution of LRI (figure 5) is very consistent all through the time period.  
There starts to be an elevated risk value in southern Asia since 1980s and it is projected 
to last till 2060s.  Aerosol loading has increased substantially in South and East Asia 
since 1979 with high level of PM2.5 distributed in eastern, southeastern, northern and 
northwestern China, northern India and part of Southeast Asia. Aerosol optical depth 
satellite results indicate the general positive trend in PM2.5 concentration projection over 
China for the past few decades. The emission in eastern Asia, especially China, can 
vary hugely according to the government policy. Dust storm also has an impact upon 
the PM2.5 variation. (EANET, 2015) 
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Figure 4 Global relative risk for cardiopulmonary disease from January to June of the three year average data from 
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 5 Global relative risk for cardiopulmonary disease from July to December  of the three year average data from 
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint.
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Figure 6 Global relative risk for cardiopulmonary disease for 6 time periods from 1850s to 1900s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
COPD disease endpoint. Note that the Saharan dust regions might present an elevated relative risk all through 6 
decades and there is no other obvious increase of risk in other regions. 
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Figure 7 Global relative risk for cardiopulmonary disease for 6 time periods from 1910s to 1960s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
COPD disease endpoint. Note that the peak value might be higher than previous decades. 
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Figure 8 Global relative risk for cardiopulmonary disease for 6 time periods from 1970s to 2020s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
COPD disease endpoint. Note that eastern Asia and other parts of Asia are associated with risk elevation since 
2000s. 
28 
 
 
Figure 9 Global relative risk for cardiopulmonary disease for 7 time periods from 2030s to 2090s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
COPD disease endpoint. Note that the elevation in Asia start to decrease since 2040s with peak value in Saharan 
and Australia consistent all through the time period. 
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Figure 10 Global relative risk for lung cancer for 6 time periods from 1850s to 1900s with the ambient PM2.5 
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al., 
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the 
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease 
endpoint. 
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Figure 11 Global relative risk for lung cancer for 6 time periods from 1910s to 1960s with the ambient PM2.5 
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al., 
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the 
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease 
endpoint. 
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Figure 12 Global relative risk for lung cancer for 6 time periods from 1970s to 2020s with the ambient PM2.5 
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al., 
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the 
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease 
endpoint. 
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Figure 13 Global relative risk for lung cancer for 7 time periods from 2030s to 2090s with the ambient PM2.5 
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al., 
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the 
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease 
endpoint. 
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Figure 14 Global relative risk for lower respiratory infection for 6 time periods from 1850s to 1900s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
LRI disease endpoint. 
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Figure 15 Global relative risk for lower respiratory infection for 6 time periods from 1910s to 1960s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
LRI disease endpoint. 
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Figure 16 Global relative risk for lower respiratory infection for 6 time periods from 1970s to 2020s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
LRI disease endpoint. 
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Figure 17 Global relative risk for lower respiratory infection for 7 time periods from 2030s to 2090s with the ambient 
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett 
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot 
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for 
LRI disease endpoint.
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The annual spatial distribution of LNC risk shows the relatively low level all through the 
time periods with a relatively high risk level in 1850s.  The risk peak in northern Africa 
regions is persistent all through all seasons and years due to the possible impact from 
massive Saharan dust storms. With the transport of Saharan dust, some regions of 
Europe might display positive effect of dust storm fine particle related health impact of 
cardiac, respiratory mortality but the effect might still be not statistically significant. 
(Karanasiou et al., 2012)  It is found that Saharan dust can transport to regions 
including United States, the Caribbean and South America, western Mediterranean, 
Europe, eastern Mediterranean and the Middle East. The elevation of risk in those 
regions is partially attributed from the Saharan dust storm.  
The Saharan region and its surroundings are responsible for 600 to 900Tg of 
atmospheric dust annually, accounting for half of the global total dust emission. The 
impact from Saharan dust would increase the relative risk due to its large amount of 
presence. The health risk from PM10 in Saharan dust is widely documented since daily 
PM10 concentration might rise to a level as high as a daily value of 4024𝜇𝑔/𝑚3 in 
extreme situation. (de Longueville et al., 2013)  The elevated risk in the Saharan 
regions and surroundings in this study might be an indication of such problem.  The dust 
loadings might change substantially due to climate change so it would be interesting to 
look into the long-term change in the dust storm particulates emission. (Goudie et. al., 
2001) 
4.3 MIROC-CHEM MODEL OUTPUT  
Figure 18 depicts the relative risk output from MIROC-CHEM model under RCP2.6 
scenario with a time range from 1850s to 2050s. 
Compared with GISS-E2-R model, MIROC-CHEM predicts an elevated relative risk in 
the region of Chile. The risk level in northern and Sub-Saharan Africa remains high all 
through the time periods. The risk level in eastern Asia is elevated since 1980s and the 
level start decreasing from 2030s. There is also an obvious elevation in Europe in 
1980s, which is consistent with the output from the GISS-E2-R model. 
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Lower respiratory infection (Figure 19) relative risk values are generally higher than 
other two diseases. Lower respiratory infection is more sensitive to exposure of surface 
PM2.5 concentration than cardiopulmonary disease or lung cancer. The reason for that is 
the reatlive risk value for LRI is higher than COPD and LNC when PM2.5 concentration 
exceeds 20.2 𝜇𝑔/𝑚3 from IER RR value table.(Apte et al., 2015) 
There is a widespread elevated risk level in the 1930s for lung cancer disease. The 
elevated values in central Asia in the 1850s are no longer perceived in other eras.  The 
difference between 1850s and 1930s might be attributed to the Gobi desert dust storm. 
(Figure 20) 
4.4 RCP SCENARIO COMPARISON  
RCP scenarios describe the trend of greenhouse gas emission in the future with RCP 
2.6 being the best scenario with the radiation forcing increase of +2.6W/m2 by 2100 and 
the emission is cut by 40% in 100 years with RCP8.5 being the worst scenario with the 
radiative forcing increase of +8.5W/m2 as the prediction of GtC increase in an order of 
15 to 20 by 2100. 
Figure 21 depicts the trend of emission of main greenhouse gases across all RCPs. 
Emission trends of air pollutants are determined by the change in driving force, the 
assumed air pollution control policy and the assumed climate policy. All the RCP 
scenarios assume that air pollution emissions would decrease in the future as a general 
trend. But generally the best greenhouse gas emission scenario RCP 2.6 is associated 
with the best scenario in air pollution emission while the worst greenhouse gas emission 
scenario RCP 8.5 is associated with the worst. Only the general trend is as described 
as above, but the trend in specific regions or at specific time is still undetermined. 
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Figure 18 Global relative risk annual plot for cardiopulmonary disease from 1850s to 2050s of the three year average 
data from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for COPD disease endpoint. 
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Figure 19 Global relative risk annual plot for lower respiratory infection disease from 1850s to 2050s of the three year 
average data from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 20 Global relative risk annual plot for lung cancer disease from 1850s to 2050s of the three year average data 
from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 21 Emissions of main greenhouse gases CO2, CH4, N2O from 2000 to 2100 across all RCPs4. The four RCPs, 
RCP2.6, RCP4.5, RCP6.0, and RCP8.5, refer to a possible range of radiative forcing values in the year 2100 
compared with pre-industrial values (+2.6, +4.5, +6.0, and +8.5 W/m2, respectively) For CO2 and N2O, the emission 
amount increase from 2000 to 2100 from highest to lowest is RCP8.5, RCP6.0, RCP4.5, RCP2.6. For methane 
emissions, RCP4.5 and RCP 6 share similar trajectory all through the time.  
                                                          
4 https://www.skepticalscience.com/RCP.php?t=3#trajectories 
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Figure 22 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for PM2.5 surface concentration from MIROC-
CHEM model output in 2030s. The ambient PM2.5 concentration is the three year average of 2030, 2031, 2032 with 
unit of µg/m3. RCP8.5 depicts the worst scenario, especially in Asia.  
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Figure 22 describes the PM2.5 concentration comparison between RCP2.6, RCP6.0.0 
and RCP8.5 scenarios for 2030 projection from MIRCO-CHEM output. 
The surface fine particle level is high in RCP8.5 scenario and low in RCP2.6 
scenario, especially for the Asian region. The highest radiative forcing (RCP8.5) 
scenario is associated with the heaviest pollution level in Asia and the Saharan 
regions.  The reason is that dust in dry regions, especially smaller particles, tends to 
be lofted into the air by wind erosion. So it is possible that dryer and hotter weather 
patterns in certain regions caused by climate change would increase the intensity or 
frequency of dust storm activities. 
However, the effect of climate change upon dust activities might be complicated and not 
just limited to air lofting. For example, dust particles both reflect and absorb sunlight and 
thus reducing the surface temperature. At the same time, the radiative forcing variation 
would alter the sea-land circulation and affect wind activities. Climate change would 
also alter monsoon and thus influencing dust storm activities since dust particles cannot 
travel long distances under very wet conditions and rainfall would cause precipitation of 
particles. (Miller et. al., 1998)  
Overall, all those interactions would contribute to the alteration in dust activities. 
The output shows the generally increased severity of dust storm effect in the Saharan 
regions, which indicates that larger wind erosion might occur with higher radiative 
forcing. 
Figure 23 depicts relative risk of cardiopulmonary disease from MIROC-CHEM model at 
2030 from RCP2.6, RCP6.0.0, RCP8.5 scenarios. Figure 24 depicts lower respiratory 
infection risk while figure 25 depicts lung cancer risk from MIROC-CHEM model at 2030 
from RCP2.6, RCP6.0.0, RCP8.5 scenarios respectively. 
RCP8.5 has the highest projected level of COPD relative risk in the 2030s. Radiative 
forcing is the factor influencing the variation.  
LRI has very varied relative risk value distribution from various scenarios.  RCP6.0.0 
has a relatively higher level in Europe region and eastern Asia than other scenarios. 
(Figure 24) 
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RCP6.0 has the highest prediction for elevated surface PM2.5 concentration level in 
eastern Asia and Australia. 
RCP 6.0 predicts a higher level of RR in eastern Asia, south-eastern Asia as well as 
western Asia compared with other scenarios in 2030s.  
GISS-E2-R has a higher prediction of LRI risk in 2030s than MIROC-CHEM model. 
Figure 26 describes the PM2.5 concentration comparison between RCP2.6, 6.0 and 8.5 
for 2050 projection from MIRCO-CHEM output. RCP6.0 pictures 2050s as more 
elevated in East Asia while RCP8.5 depicts the high concentration in Saharan regions. 
Figure 27, 28, 29 depict the relative risk value comparison between RCP2.6, 6.0 and 
8.5 for COPD,LNC,LRI  respectively for 2050 projection from MIRCO-CHEM. 
The highest risk elevation in Asia is for RCP6.0.0 scenario while the highest risk 
elevation in northern Africa is for RCP8.5 scenario in 2050s. 
For the MIROC-CHEM model output in 2050s, RCP6.0.0 predicts an elevated level in 
eastern Asia while RCP8.5 predicts a higher level in southern Africa.  
So the relative risk for LNC is elevated in eastern and south-eastern Asia for RCP6.0.0 
while it is elevated in western and southern Asia for RCP8.5. RCP8.5 also predicts an 
elevated level in southern Africa.  
Figure 30 describes the PM2.5 concentration comparison between RCP2.6,4.5, 6.0 and 
8.5 for 2050 projection from GISS-E2-R output. 
RCP 6.0 is the only scenario that predicts elevated PM2.5 in eastern Asia for 2050s. 
Figure 31 describes the COPD relative risk comparison between RCP2.6,4.5, 6.0 and 
8.5 for 2050 projection from GISS-E2-R output. 
RCP 6.0 predicted an elevated risk level in eastern Asia in 2050s. 
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Figure 23 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk from 
MIROC-CHEM model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP8.5 
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.  
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Figure 24 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lower respiratory infection disease relative risk 
from MIROC-CHEM model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. 
RCP8.5 depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.  
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Figure 25 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lung cancer relative risk from MIROC-CHEM 
model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP8.5 depicts the 
worst scenario, especially with a widespread elevation in relative risk over Asia.  
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Figure 26 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for PM2.5 surface concentration from MIROC-
CHEM model output in 2050s. The ambient PM2.5 concentration is the three year average of 2050, 2051, 2052 with 
unit of µg/m3. RCP8.5 depicts the worst scenario, especially in Asia. 
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Figure 27 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk from 
MIROC-CHEM model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5 
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia. 
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Figure 28 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lung cancer relative risk from MIROC-CHEM 
model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5 depicts the 
worst scenario, especially with a widespread elevation in relative risk over Asia. 
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Figure 29 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lower respiratory infection relative risk from 
MIROC-CHEM model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5 
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.  
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Figure 30 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for PM2.5 concentration (unit:µg/m3) from 
GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. 
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Figure 31 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk 
from GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. 
RCP6.0 scenario predicts the highest risk level in eastern Asia. 
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Figure 32 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for lung cancer relative risk from GISS-
E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP6.0 scenario 
predicts the highest risk level in eastern Asia. 
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Figure 33 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for lower respiratory infection disease 
relative risk from GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 
2032. RCP6.0 scenario predicts the highest risk level in eastern Asia. 
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Figure 34 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for PM2.5 concentration (unit: µg/m3) 
from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. 
 
 
 
58 
 
 
Figure 35 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for cardiopulmonary disease relative 
risk from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. 
RCP6.0.0 scenario predicts the highest risk level in eastern Asia. 
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Figure 36 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for lung cancer disease relative risk 
from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. 
RCP6.0.0 scenario predicts the highest risk level in eastern Asia. 
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Figure 37 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for lower respiratory infection relative 
risk from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. 
RCP6.0.0 scenario predicts the highest risk level in eastern Asia. 
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4.5 COMPARISON BETWEEN MODELS 
 
Figure 38 The comparison of ambient PM2.5 concentration between various models (CICERO-OsloCTM2, MIROC-
CHEM, NCAR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R) in 1850s. CICERO-OsloCTM2 predicts surface 
concentration in an obvious different way compared with other models while NCAR-CAM3.5 has a generally higher 
prediction. 
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Figure 39 multi-ensemble results for COPD relative risk for 1850s with the unweighted average of cardiopulmonary 
relative risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R. 
 
 
 
Figure 40 multi-ensemble results for LNC relative risk for 1850s with the unweighted average of lung cancer relative 
risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R. 
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Figure 41 Multi-ensemble results for lower respiratory infection relative risk for 1850s with the unweighted average of 
lung cancer relative risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R. 
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Figure 42 The comparison of ambient PM2.5 concentration between various models (CICERO-OsloCTM2, MIROC-
CHEM, NCAR-CAM3.5, NCAR-CAM5.1, GISS-E2-R, GFDL-AM3) in 2000s. CICERO-OsloCTM2 predicts surface 
concentration in an obvious different way compared with other models while GFDL-AM3 has a generally higher 
prediction. 
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Figure 43 Multi-ensemble results for cardiopulmonary disease relative risk for 2000s with the unweighted average 
from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3. 
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Figure 44 Multi-ensemble results for lung cancer relative risk for 2000s with the unweighted average output from 
models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3. 
 
Figure 45 Multi-ensemble results for lower respiratory infection relative risk for 2000s with the unweighted average 
output from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3. 
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Figure 46 Multi-ensemble results for dust concentration for 2000s with the unweighted average from models including 
MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3. 
 
 
Figure 38 describes the model comparison for pre-industrial projection of near surface 
PM2.5 concentration from CICERO, MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and 
GISS-E2-R. 
NCAR-CAM3.5 has a much higher level of PM2.5 output for 1850s. CICERO-OsloCTM2 
has a very different output compared with other models which can be explained by the 
lack of continuous data around 1850 and the cumulated deviation of adding up 
composition components. 
Model comparison shows the outliner value for CICERO, so this model would not be 
used for multi-model ensemble.  Models comparison for 1850s shows obvious elevation 
of relative risk of LRI for NACR-CAM3.5. 
Figure 39,40,41 show the ensemble results from MIROC-CHEM, NACR-CAM3.5, 
NCAR-CAM5.1, GISS-E2-R for relative risk of COPD,LNC,LRI in 1850s. The ensemble 
results provide the distribution of risk with lower uncertainty from model difference.  
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Figure 42 describes the model comparison for current year (2000s) projection of near 
surface PM2.5 concentration from GFDL-AM3, CICERO-OsloCTM2, MIROC-CHEM, 
NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R. Compared with 1850s, NCAR-CAM3.5 
predicts an elevated level in southern America. GFDL-AM3 predicts a commonly 
elevated value over the globe and it is shown that the Saharan dust pollution spread to 
further range than other models. While GISS-E2-R predicts an elevation in central 
Australia, MIROC-CHEM predicts almost no elevation in this region.  For 2000s, 
CICERO-OsloCTM2 still presents outliner data range compared with others and it would 
not be used to calculate the unweighted mean value for the multi-ensemble. 
Due to the availability of data, only one year’s data is used for NCAR-CAM3.5, which 
might contributes to the uncertainty in unweighted mean results.  Multi-model ensemble 
is conducted for the output from all five models including GFDL-AM3, GISS-E2-R, 
MIROC-CHEM, NCAR-CAM3.5 and NCAR-CAM5.1 for 2000s. 
Figure 43,44,45 show the ensemble results from GFDL-AM3, MIROC-CHEM, NACR-
CAM3.5, NCAR-CAM5.1, GISS-E2-R for relative risk of COPD,LNC,LRI respectively in 
2000s. The ensemble results indicate that the elevation of relative risk in East Asia 
cannot be attributed to dust impact since dust concentration ensemble shows a near 
background level of dust concentration in that region. The increased anthological 
emission associated with industrial development and population growth in East Asia is 
responsible for such elevation and increase between preindustrial times and current 
years. 
 
There is an obvious increase from 1850 to 2000 in East Asia due to the increasing 
anthological emission while Saharan or Australia dust effect almost remain the same.  
Increase is also observed in Arabian Peninsula, which is associated with increasing 
dust load and a much smaller increase in secondary inorganic and carbonaceous 
aerosol. (Boys et al., 2014)  Multi-ensemble results are very important for depicting the 
risk distribution in a more accurate way compared with single model.  An obvious 
elevation is observed in Central Australia from the ensemble results.  
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 Short-term health impact from Australia dust storm is proved in Merrifield’s study. 
Australia dust storm has been found to be linked to daily hospital visits in Sydney in 
Merrifield’s study. Asthma risk increased to 1.23 and respiratory risk increased to 1.20 
for that period of time. (Merrifield et. al., 2013) Although chronic exposure is hard to 
prove significant statistically in cohort studies but the model output does depicts the 
elevation for chronic disease including cardiopulmonary disease and lower respiratory 
infection for the populated regions including major cities and regional area. The dust 
concentration ensemble output further indicates the dust peak in the central region of 
Australia. 
The ensemble output of dust concentration is presented in figure 46 for 2000s. The 
elevation in dust concentration in Mediterranean and Saudi Arabic are very likely to be 
responsible for the elevated relative risk from ensemble output.  
 
4.6 POPULATION VARIANCE BETWEEN MODELS 
Population Variance was calculated and plotted for 1850-1852 (figure 47) and 2000-
2002 (figure 48) from four models (MIROC-CHEM, NCAR-CAM3.5, NCAR-CAM5.1 and 
GISS-E2-R) for gird data.  There is relatively a much higher variance for LRI than other 
diseases between various models. 
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Figure 47 The variance of the prediction of ambient PM2.5 concentration derived relative risk for cardiopulmonary 
disease, lung cancer and lower respiratory infection between various models (MIROC-CHEM,NCAR-CAM3.5,NCAR-
CAM5.1,GISS-E2-R) in 1850s. Higher variance value would indicate a more spread out status of various models. It is 
worth noticing that lower respiratory infection relative risk has a much higher variance level than other disease 
endpoints, which means that there would be more uncertainty coming from LRI relative risk output from model 
difference. 
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Figure 48 The variance of the prediction of ambient PM2.5 concentration derived relative risk for cardiopulmonary 
disease, lung cancer and lower respiratory infection between various models (MIROC-CHEM,NCAR-CAM3.5,NCAR-
CAM5.1,GISS-E2-R) in 2000s. Higher variance value would indicate a more spread out status of various models.  
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4.7 GRID AVERAGE DATA FROM PRE-INDUSTRIAL TIME TO 
PRESENT 
By calculating the average value of relative risk from each time period, the tendency of 
risk variation can be derived from the results to measure the exposure change globally 
speaking. Figure 49 shows the grid average of the relative risk for cardiopulmonary 
disease from 1850s (pre-industrial) to 2010s (current years). There is a general trend of 
elevation in grid–averaged relative risk value from1850s to 2010s. The RR value peaks 
in 1980s. 
Figure 76, 77 in the appendix show the grid average of the relative risk for lung cancer 
and lower respiratory infection respectively from 1850s (pre-industrial) to 2010s (current 
years). 
The variation in LRI relative risk value is relatively high while variation in COPD relative 
risk value is low. 
4.8 POPULATION NORMALIZED OUTPUT 
Population normalization is conducted to measure the surface air pollution related to 
human exposure. Such measure is used as in Apte’s study as a way to emphasize the 
effect of population exposure. (Apte et al., 2015)  Regions were divided to analyze the 
regional distribution related to development level and geography.  
The population normalized relative risk value for CIS regions peaks in January and 
October. Developed countries peak in April. Northern Africa peaks in February and 
November. Southern Asia peaks in February and December. Latin America and 
Caribbean peak in January and October. Oceania peaks in September. Western Asia 
peaks in February and December. Eastern Asia peaks in March. Developed countries 
peak in April. Sub-Saharan peaks in March. 
There is a sudden drop of normalized relative risk value for COPD in December for 
Northern Africa. (See Table 1) RCP6.0 predicts a relatively higher concentration level 
while RCP2.6 predicts lower level. There is an increase of predicted normalized surface 
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PM2.5 concentration for developed countries while there is a general decrease trend for 
other regions. 
In SSP2 scenario, CIS regions is predicted with a much lower normalized PM2.5 
concentration compared with SSP1 while there is not much different between two 
scenarios for other regions. (See Table 2) Such result indicate that a moderately 
sustainable population scenario would predict a lower level of population exposure in 
CIS. 
Table 3 shows the population normalized relative risk value for various regions under 
emission scenarios including RCP2.6,6.0,8.5 and time periods including 
2000,2030,2050. The population scenario utilized is SSP1 and the results describe the 
regional risk distribution from the output of MIROC-CHEM model. For the same 
population scenario and RCP scenario, MIROC-CHEM actually predicts a much lower 
normalized PM2.5 concentration value level compared with GISS-E2-R. 
 
 
 
Figure 49 Grid averaged COPD relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of 
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since 
pre-industrial times. 
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TABLE 1 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios 
 
 
 
regions 
GISS-E2-R 
SSP1 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 9.64 8.841 9.219 9.152 9.01 8.716 8.756 8.872 8.77 
developed countries 16.90 17.384 17.899 17.726 17.37 17.54 17.436 17.578 17.493 
Sub-Saharan Africa 7.32 6.768 7.293 6.861 6.768 6.7 6.843 7.15 6.779 
Eastern Asia 12.04 11.23 11.528 11.665 11.479 11.233 11.033 11.456 11.26 
Latin America and the Caribbean 17.45 16.668 16.963 17.576 16.065 16.631 16.693 17.338 17.282 
Northern Africa 11.99 13.22 12.902 13.03 13.07 13.196 13.003 12.861 12.938 
Oceania 8.84 8.487 8.025 7.936 8.014 8.451 8.012 8.559 8.813 
Southern Asia 6.85 6.331 5.999 6.137 5.908 6.288 5.355 5.971 5.884 
South-Eastern Asia 8.15 7.669 7.506 8.674 8.425 7.708 6.603 8.584 8.56 
Western Asia 13.48 13.001 13.63 13.345 13.12 12.92 12.955 13.332 12.794 
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TABLE 2 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios           
 
 
 
regions 
GISS-E2-R 
SSP2 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 9.059 7.703 7.984 8.044 7.885 7.545 7.448 7.68 7.544 
developed countries 16.896 17.401 17.92 17.745 17.389 17.547 17.486 17.62 17.55 
Sub-Saharan Africa 7.3167 6.76 7.285 6.854 6.757 6.774 6.867 7.154 6.77 
Eastern Asia 12.016 11.197 11.504 11.626 11.446 11.204 10.977 11.41 11.20 
Latin America and the Caribbean 17.447 16.653 16.954 17.559 16.059 17.265 16.666 17.302 17.26 
Northern Africa 13.055 13.223 12.9 13.027 13.069 12.929 12.994 12.85 12.93 
Oceania 8.836 8.483 8.02 7.93 8.008 8.806 8.004 8.554 8.806 
Southern Asia 6.8832 6.334 5.98 6.132 5.883 5.851 5.315 5.927 5.851 
South-Eastern Asia 8.8398 8.504 8.34 9.445 9.156 9.475 7.323 9.324 9.475 
Western Asia 13.476 13 13.626 13.34 13.116 12.783 12.945 13.317 12.78 
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TABLE 3 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR MIROC-CHEM MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH POPULATION 
SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK. 
region MIROC-CEHM 
SSP1 
2000 2030 2050 
hist RCP2.6 RCP6.0 RCP8.5 RCP2.6 RCP6.0 RCP8.5 
CIS 1.569 1.069 1.386 1.32 0.934 1.295 1.209 
developed countries 7.256 7.909 7.962 8.837 8.219 7.121 9.717 
Sub-Saharan Africa 1.073 1.082 1.131 1.077 1.015 1.069 1.146 
Eastern Asia 3.973 2.606 3.052 2.342 2.109 2.421 2.053 
Latin America and the Caribbean 5.102 5.954 5.877 6.139 4.884 6.608 6.00 
Northern Africa 1.672 1.407 1.538 1.531 1.236 1.531 1.461 
Oceania 1.927 2.078 1.898 1.772 1.941 1.924 2.121 
Southern Asia 4.197 3.422 3.199 3.014 2.595 2.679 2.729 
South-Eastern Asia 4.925 0.004 4.576 1.077 4.013 4.317 4.09 
Western Asia 1.781 1.331 1.509 1.508 1.226 1.428 1.442 
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TABLE 4 POPULATION NORMALIZED COPD RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios 
 
 
 
regions 
GISS-E2-R 
SSP1 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 1.0515 1.048 1.05 1.0496 1.049 1.0479 1.048 1.0485 1.048 
developed countries 1.0777 1.079 1.081 1.0804 1.0794 1.0799 1.079 1.08 1.08 
Sub-Saharan Africa 1.0425 1.04 1.042 1.0408 1.0404 1.0401 1.0408 1.0418 1.04 
Eastern Asia 1.0609 1.058 1.059 1.0594 1.0587 1.0578 1.057 1.0586 1.058 
Latin America and the Caribbean 1.0788 1.076 1.077 1.0791 1.074 1.076 1.0756 1.0784 1.078 
Northern Africa 0.9962 1.065 1.064 1.0646 1.0647 1.0651 1.064 1.0639 1.064 
Oceania 1.0485 1.047 1.045 1.045 1.0453 1.047 1.0453 1.0474 1.048 
Southern Asia 1.0409 1.039 1.038 1.0381 1.0372 1.037 1.035 1.0374 1.037 
South-Eastern Asia 1.0456 1.044 1.043 1.0476 1.0466 1.0439 1.04 1.0472 1.047 
Western Asia 1.0662 1.064 1.067 1.0657 1.0648 1.064 1.0642 1.0656 1.064 
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TABLE 5 POPULATION NORMALIZED COPD RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios 
 
 
 
regions 
GISS-E2-R 
SSP2 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 1.049 1.044 1.045 1.045 1.0447 1.0434 1.043 1.044 1.043 
developed countries 1.078 1.079 1.081 1.08 1.0794 1.0799 1.08 1.08 1.08 
Sub-Saharan Africa 1.0425 1.040 1.042 1.041 1.0403 1.0404 1.041 1.042 1.04 
Eastern Asia 1.0608 1.058 1.059 1.059 1.0586 1.0577 1.057 1.059 1.058 
Latin America and the 
Caribbean 1.0788 
1.076 1.077 1.079 1.074 1.0777 1.075 1.078 1.078 
Northern Africa 1.0646 1.066 1.064 1.064 1.0647 1.0641 1.064 1.064 1.064 
Oceania 1.0485 1.047 1.045 1.045 1.0453 1.0483 1.045 1.047 1.048 
Southern Asia 1.041 1.039 1.037 1.038 1.0371 1.037 1.035 1.037 1.037 
South-Eastern Asia 1.048 1.047 1.046 1.05 1.0494 1.0505 1.042 1.05 1.050 
Western Asia 1.0662 1.064 1.067 1.066 1.0648 1.0635 1.064 1.0656 1.064 
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Table 4 and table 5 show that the relative risk value for COPD from GISS-E2-R model 
output with SSP2 has much lower value for CIS region than SSP1. The COPD risk 
value with SSP2 for south-eastern Asia is much higher than that with SSP1. There is a 
slight lowering trend from 2000 to 2050 with SSP2 dataset while the different between 
different RCP scenarios is limited.  
For CIS region, relative risk for LRI with SSP2 dataset has lower value than SSP1. The 
different between SSP1 and SSP2 for relative risk of LRI for other regions is very 
limited. (See Table 8&9) The LRI relative risk values for regions including CIS, Sub-
Saharan Africa, Oceania, South-Eastern Asia are around 1, so the health risk of lower 
respiratory infection for those regions from surface PM2.5 exposure is very limited. 
The normalized PM2.5 data for CIS, northern Africa, Oceania, Sub-Saharan Africa, south 
Asia regions with SSP3 is much lower than SSP1 and SSP2 under the same RCP 
scenarios and models.  While normalized concentration or risk value for eastern Asia, 
east Asia and Latin America and the Caribbean are predicted with much higher values 
with SSP3.(See Table 10)
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TABLE 6 POPULATION NORMALIZED LNC RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios           
 
 
 
regions 
GISS-E2-R 
SSP1 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 1.0625 1.057 1.059 1.06 1.0586 1.0566 1.0573 1.0579 1.0571 
developed countries 1.0994 1.103 1.11 1.1064 1.1038 1.1037 1.1065 1.1046 1.106 
Sub-Saharan Africa 1.0501 1.046 1.047 1.0487 1.0437 1.0454 1.0455 1.0474 1.0422 
Eastern Asia 1.046 1.069 1.07 1.074 1.0403 1.0688 1.0705 1.0727 1.0711 
Latin America and the Caribbean 1.1 1.095 1.103 1.103 1.0985 1.0952 1.098 1.1013 1.1082 
Northern Africa 1.0094 1.081 1.081 1.0821 1.083 1.0812 1.0816 1.0802 1.0802 
Oceania 1.0554 1.055 1.051 1.0525 1.052 1.0552 1.0516 1.057 1.0576 
Southern Asia 1.046 1.042 1.0403 1.0418 1.0403 1.0421 1.0361 1.0409 1.0387 
South-Eastern Asia 1.0538 1.048 1.05 1.0583 1.05256 1.0484 1.0445 1.0563 1.0498 
Western Asia 1.0856 1.082 1.085 1.0848 1.0827 1.0812 1.081 1.0833 1.079 
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TABLE 7 POPULATION NORMALIZED LNC RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios           
 
 
 
regions 
GISS-E2-R 
SSP2 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 1.059 1.051 1.052 1.053 1.0518 1.05 1.05 1.051 1.05 
developed countries 1.099 1.103 1.11 1.106 1.104 1.1063 1.107 1.105 1.106 
Sub-Saharan Africa 1.0501 1.046 1.047 1.049 1.1044 1.0422 1.045 1.047 1.042 
Eastern Asia 1.0768 1.068 1.072 1.074 1.0708 1.0707 1.07 1.073 1.0707 
Latin America and the 
Caribbean 1.1 
1.095 1.103 1.103 1.0985 1.1081 1.1 1.101 1.108 
Northern Africa 1.079 1.082 1.081 1.082 1.083 1.08 1.082 1.08 1.08 
Oceania 1.055 1.055 1.051 1.052 1.052 1.0575 1.051 1.057 1.058 
Southern Asia 1.046 1.042 1.04 1.042 1.04 1.0385 1.036 1.041 1.038 
South-Eastern Asia 1.058 1.052 1.055 1.063 1.0568 1.0545 1.049 1.061 1.0545 
Western Asia 1.0856 1.082 1.085 1.085 1.0827 1.0789 1.081 1.083 1.0789 
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TABLE 8  POPULATION NORMALIZED LRI RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios           
 
 
 
regions 
GISS-E2-R 
SSP1 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 0.9871 0.975 0.981 0.9795 0.978 0.9737 0.9742 0.976 0.9744 
developed countries 1.0836 1.09 1.096 1.0933 1.0897 1.0918 1.0896 1.093 1.0911 
Sub-Saharan Africa 0.9535 0.946 0.953 0.947 0.946 0.9446 0.9473 0.951 0.9458 
Eastern Asia 1.0221 1.011 1.015 1.0167 1.014 1.0107 1.0078 1.014 1.0109 
Latin America and the 
Caribbean 1.0871 
1.077 1.079 1.0879 1.0694 1.077 1.0746 1.0853 1.0827 
Northern Africa 0.9669 1.038 1.034 1.0358 1.0362 1.038 1.0351 1.0332 1.0342 
Oceania 0.9759 0.971 0.964 0.9627 0.964 0.97 0.9639 0.9718 0.9753 
Southern Asia 0.9475 0.94 0.935 0.9371 0.9339 0.939 0.9258 0.9346 0.9335 
South-Eastern Asia 0.9651 0.958 0.956 0.9724 0.9687 0.959 0.9432 0.9709 0.9703 
Western Asia 1.0417 1.035 1.044 1.04 1.0367 1.034 1.0343 1.04 1.032 
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TABLE 9 POPULATION NORMALIZED LRI RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP 
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH 
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE 
RISK. 
scenarios           
 
 
 
regions 
GISS-E2-R 
SSP2 
2000 2030 2050 
hist RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CIS 0.9788 0.959 0.963 0.964 0.962 0.9568 0.9554 0.9588 0.9568 
developed countries 1.0836 1.09 1.096 1.094 1.09 1.092 1.09 1.0935 1.0917 
Sub-Saharan Africa 0.9535 0.945 0.953 0.947 0.945 0.9457 0.947 0.951 0.9457 
Eastern Asia 1.022 1.01 1.014 1.016 1.014 1.0101 1.007 1.0137 1.01 
Latin America and the Caribbean 1.087 1.077 1.079 1.088 1.069 1.0825 1.074 1.0848 1.0824 
Northern Africa 1.0359 1.039 1.034 1.036 1.036 1.0341 1.035 1.0331 1.034 
Oceania 0.9758 0.97 0.964 0.963 0.964 0.9752 0.964 0.9717 0.9752 
Southern Asia 0.948 0.94 0.935 0.937 0.934 0.933 0.925 0.934 0.933 
South-Eastern Asia 0.9749 0.97 0.967 0.983 0.979 0.9832 0.954 0.9814 0.9832 
Western Asia 1.0417 1.035 1.044 1.04 1.037 1.0319 1.034 1.0395 1.0319 
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TABLE 10 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER 
POPULATION SCENARIO SSP3 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO AND 
GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK. 
 GISS-E2-R SSP3 
Regions  2000 
hist 
PM2.5 COPD LNC LRI 
CIS 7.984 1.045 1.052 0.963 
DC  17.921  1.081  1.11  1.096 
EA  11.504  1.059  1.072  1.014 
LAC  16.954  1.077  1.103  1.079 
NA  12.9  1.064  1.081  1.034 
O  8.02  1.045  1.051  0.964 
SA  5.979  1.037  1.04  0.935 
SEA  8.34  1.046  1.055  0.967 
SSA  7.285  1.042  1.047  0.953 
WA  13.626  1.067  1.085  1.044 
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TABLE 11 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER 
POPULATION SCENARIO SSP3 AND EMISSION SCENARIOS (RCP2.6,RCP4.5,RCP6.0,RCP8.5) FOR THE TIME PERIOD OF 2030S AS MEASURING THE 
EFFECT OF BOTH POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION 
NORMALIZED RELATIVE RISK. 
GISS-E2-R SSP3 
Regions 2030  
RCP2.6 RCP4.5 RCP6.0 RCP8.5 
PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI 
CIS  7.43 1.043  1.049  0.955  7.68 1.044   1.05  0.959 7.79   1.044 1.052  0.96  7.62 1.044 1.05 0.958 
DC 17.40 1.079 1.103 1.09 17.94 1.081 1.11 1.096 17.73 1.08 1.106 1.094 17.4 1.079 1.104 1.09 
EA  11.22  1.058  1.069  1.01  11.52  1.059  1.072  1.015  11.66  1.059  1.074  1.017 11.47 1.059 1.071 1.01 
LAC  16.61  1.076  1.095  1.077  16.92  1.077  1.103  1.079  17.5  1.079  1.103  1.087 16.04 1.074 1.098 1.069 
NA  13.16  1.065  1.081  1.037  12.85  1.064  1.08  1.033  12.96  1.064  1.082  1.035 13.05 1.064 1.083 1.036 
O  8.49  1.047  1.055  0.971  8.02  1.045  1.05  0.964  7.94  1.045  1.052  0.963 8.01 1.045 1.052 0.964 
SA  6.31  1.039  1.042  0.939  5.95  1.037  1.04  0.935  6.12  1.038  1.042  0.937 5.89 1.037 1.04 0.934 
SEA  7.73  1.044  1.048  0.959  7.58  1.043  1.05  0.957  8.74  1.048  1.059  0.973 8.5 1.047 1.053 0.97 
SSA  6.84  1.041  1.046  0.946  6.5  0.92  0.924  0.842  6.9  1.041  1.049  0.948 6.031 0.918 0.921 0.835 
WA  12.96  1.064  1.081  1.035  13.59  1.067  1.084  1.043  13.29  1.066  1.084  1.039 13.12 1.065 1.082 1.04 
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TABLE 12 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER 
POPULATION SCENARIO SSP3 AND EMISSION SCENARIOS (RCP2.6,RCP4.5,RCP6.0,RCP8.5) FOR THE TIME PERIOD OF 2050S AS MEASURING THE 
EFFECT OF BOTH POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION 
NORMALIZED RELATIVE RISK. 
GISS-E2-R SSP3 
Regions 2050 
RCP2.6 RCP4.5 RCP6.0 RCP8.5 
PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI 
CIS 6.84 1.0406 1.0455 0.9466 6.96 1.041 1.047 0.948 7.235 1.042 1.048 0.952 7.089 1.042 1.047 0.95 
DC  17.54 1.0799 1.1061 1.091  17.54 1.08 1.107 1.091  17.68 1.08 1.105 1.094  17.622 1.08 1.107 1.093 
EA  11.01 1.0569 1.07 1.007  11 1.057 1.07 1.007  11.43 1.058 1.072 1.013  11.231 1.058 1.071 1.01 
LAC  15.12 1.0706 1.089 1.0568  16.55 1.075 1.097 1.073  17.21 1.078 1.1 1.084  17.181 1.077 1.108 1.081 
NA  12.63 1.063 1.079 1.03  12.95 1.064 1.081 1.034  12.82 1.064 1.08 1.033  12.891 1.064 1.08 1.033 
O  7.69 1.0441 1.049 0.9595  8 1.045 1.051 0.964  8.56 1.047 1.057 0.972  8.812 1.048 1.058 0.975 
SA  5.567 1.0358 1.038 0.9288  5.304 1.035 1.036 0.925  5.92 1.037 1.041 0.934  5.831 1.037 1.038 0.933 
SEA  8.75 1.0477 1.057 0.9728  6.78 1.04 1.046 0.946  8.77 1.048 1.057 0.974  8.774 1.048 1.051 0.973 
SSA  7.06 1.0415 1.046 0.9497  6.905 1.04 1.046 0.948  7.22 1.042 1.048 0.952  6.805 1.04 1.042 0.946 
WA  12.77 1.0635 1.079 1.032  12.96 1.064 1.08 1.034  13.28 1.065 1.083 1.039  12.792 1.064 1.079 1.032 
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Table 11 and table 12 depict population normalized PM2.5 concentration, COPD risk, 
LNC risk, LRI risk for GISS-E2-R model under population scenario SSP3 and emission 
scenarios (RCP2.6,RCP4.5,RCP6.0,RCP8.5) for the time period of 2030s and 2050s 
respectively. 
With SSP3 as the population scenario, RCP6.0 represents a higher level of normalized 
value for regions including CIS, DC, EA, LAC, SA, SSA and WA.  
From the GISS-E2-R and SSP3, it is shown that there is generally a decreasing trend of 
population normalized PM2.5 concentration and related relative risk from 2000s to 2050s 
for various scenarios.  
Among various emission scenarios, RCP6.0 predicts the highest surface pollution level 
in the future while RCP2.6 predicts the lowest. From 2000s to 2050s, the equivalent 
carbon dioxide increase ranks from high to low as RCP8.5, RCP4.5, RCP6.0 and 
RCP2.6.  The reason for such distribution is due to the difference in radiative forcing 
value settings.  Population normalized concentration is more useful in predicting human 
exposure derived health impact because the relative risk for each grid would be 
substantially lower if the population for such grid is extremely low. Such calculation 
would avoid situation of the too high or too low relative risk in regions with low 
population causing effect on the overall relative risk or concentration.  
For regional distribution, developed countries and Latin America have the highest 
population normalized concentration and associated relative risk with western Asia and 
Southern Asia come next. 
Surface PM2.5 exposure has a much lower effect upon chronic lower respiratory infection 
while has a much higher effect upon LNC and COPD.  In Jassen’s study (Janssen et al., 
2011), black carbon is used as additional predictor for health impact since black carbon 
is more toxic than the other component in PM2.5. In their study, assumption was made 
about that black carbon is 5 times more toxic than the other components so black 
carbon mass is multiplied by 5 to adjust the health impact related PM2.5 concentration. It 
was concluded black carbon is a valuable tool to predict health impact.  
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For further optimizing the output for health risk, black carbon mass adjusted PM2.5 mass 
concentration and derived relative risks are calculated for NACR-CAM5.1 model output 
for the three year average of surface PM2.5 concentration of 2000 to 2002. 
The original calculation function for PM2.5 mass concentration:  
PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust 
The adjusted calculation function for PM2.5 mass concentration:  
PM2.5=5*BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust 
The point in adjusting relative risk with black carbon concentration is to discover 
whether it should be necessary to consider the effect from black carbon since IER 
model or other C-R functions may only take the mass concentration of particulate matter 
into consideration instead of assessing the health impact regarding the toxicity of all the 
components.  
Different population scenarios might have slight impact on population normalized fine 
particle surface concentration but the resulted relative risk change is very trivial.  
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TABLE 13 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR NCAR-CAM5.1  MODEL UNDER 
POPULATION SCENARIO SSP1,SSP2,SSP3 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO AND 
GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK. 
region NCAR-CAM 5.1 SSP1 NCAR-CAM 5.1 SSP2 NCAR-CAM 5.1 SSP3 
2000 2000 2000 
PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI PM2.5 COPD LNC LRI 
CIS 4.018 1.0299 1.0294 0.9064 3.954 1.03 1.029 0.9054 3.924 1.03 1.0288 0.905 
developed countries 16.75 1.0698 1.091 1.0476 16.75 1.07 1.091 1.0476 16.75 1.07 1.091 1.048 
Sub-Saharan Africa 7.489 1.0433 1.0484 0.9566 7.489 1.043 1.048 0.9565 7.581 1.044 1.0488 0.958 
Eastern Asia 6.2 1.0384 1.0417 0.9384 6.238 1.038 1.0419 0.939 6.2 1.038 1.04169 0.938 
Latin America and the 
Caribbean 
10.712 1.0554 1.0666 1.001 10.712 1.055 1.0666 1.001 10.71 1.055 1.0666 1.001 
Northern Africa 6.409 1.0392 1.0435 0.9415 6.409 1.039 1.0435 0.9415 6.382 1.039 1.0433 0.941 
Oceania 9.178 1.0499 1.0584 0.9811 9.177 1.05 1.058 0.9811 9.178 1.04989 1.0584 0.981 
Southern Asia 7.244 1.0425 1.0476 0.9534 7.245 1.042 1.0477 0.9534 7.244 1.0425 1.0476 0.953 
South-Eastern Asia 14.166 1.0682 1.0877 1.049 13.573 1.066 1.0846 1.041 14.166 1.0682 1.0877 1.049 
Western Asia 6.302 1.0388 1.0426 0.9399 6.302 1.0388 1.0426 0.9399 6.378 1.0391 1.043 0.941 
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TABLE 14 POPULATION NORMALIZED BLACK CARBON ADJUSTED NEW PM2.5 CONCENTRATION, COPD 
RISK, LNC RISK, LRI RISK RESPECTIVELY FOR NCAR-CAM5.1  MODEL UNDER POPULATION SCENARIO 
SSP1 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO 
AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION 
NORMALIZED RELATIVE RISK. 
region NCAR-CAM 5.1 SSP1 
2000 
NEWPM2.5 RRCOPD RRLNC RRLRI 
CIS 4.11 1.0302 1.0300 0.9078 
developed countries 17.03 1.0708 1.0925 1.0511 
Sub-Saharan Africa 7.52 1.0434 1.0485 0.957 
Eastern Asia 6.33 1.0389 1.0425 0.9403 
Latin America and the Caribbean 11.8 1.0593 1.0728 1.0159 
Northern Africa 6.437 1.0394 1.0437 0.942 
Oceania 9.41 1.0508 1.0598 0.9844 
Southern Asia 7.737 1.0444 1.0505 0.9605 
South-Eastern Asia 14.62 1.0699 1.0902 1.055 
Western Asia 6.345 1.0390 1.0428 0.9405 
 
 
From table 13 and table 14, the comparison between original PM2.5 and derived relative 
risk and black carbon adjusted value is made to test whether the approach of black 
carbon adjustment of relative risk would be necessary to alter the current methodology 
of only taking mass concentration into consideration when measuring health impact. If 
the difference between non-adjustment and adjustment is big enough, the toxicity of 
black carbon should also be regarded when calculating relative risk. 
The increase in COPD relative risk for various regions from SSP1 scenarios: 
CIS:0.03%; DC:0.09%; SSA:0.01%; EA:0.05%; LAC:0.37%; NA:0.02%; O:0.086%; 
SA:0.2%; SEA:0.16%, WA:0.02% 
From the increase in black carbon adjusted relative risk for COPD disease, it is shown 
that Latin America and the Caribbean and southern Asia would be facing relatively 
higher COPD exposure risk with the black carbon influence while there is not much 
black carbon COPD risk in Sub-Saharan Africa, western Asia or CIS. 
91 
 
The increase in LNC relative risk for various regions from SSP1 scenarios: 
CIS:0.06%; DC:0.14%; SSA:0.01%; EA:0.39%; LAC:0.58%; NA:0.02%; O:0.13%; 
SA:0.28%; SEA:0.23%, WA:0.02% 
From the increase in black carbon adjusted relative risk for LNC disease, it is shown 
that Latin America and the Caribbean and Eastern Asia would be facing relatively higher 
LNC exposure risk with the black carbon influence while there is not much black carbon 
LNC risk in Sub-Saharan Africa, western Asia or Northern Africa. It is worth noting that 
there is large increase in LNC risk compared with COPD risk for eastern Asia. LNC 
derived relative risk might be much more sensitive for black carbon compared with 
COPD or LRI. 
The increase in LRI relative risk for various regions from SSP1 scenarios: 
CIS:0.15%; DC:0.33%; SSA:0.04%; EA:0.2%; LAC:1.49%; NA:0.05%; O:0.34%; 
SA:0.74%; SEA:0.57%, WA:0.06% 
From the increase in black carbon adjusted relative risk for LRI disease, it is shown that 
southern Asia and South-eastern Asia would be facing relatively higher LRI exposure 
risk with the black carbon influence while there is not much black carbon LRI risk in 
South-eastern Africa or western Asia.  There is an extremely high increase in the 
relative risk for LAC. LAC region is more sensitive to black carbon surface pollution 
compared with other regions. 
Table 15 and 16 depict the COPD mortality from GISS-E2-R output under population 
scenario SSP1, SSP2 and SSP3 for the time period of 2000s and 2050s respectively. 
For lower respiratory infection premature mortality, the difference is much higher and 
should take black carbon toxicity into consideration for higher accuracy since lower 
respiratory infection risk would be higher than other two diseases when PM2.5 exceeds 
20.2 µg/m3. 
Mortality in eastern Asia is Southern Asia are highest among all regions in current days 
or near future. There is an obvious increase in mortality in Southern Asia while slightly 
decreased mortality in Eastern Asia. There is a very slight decrease in the population 
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average risk value so the relatively large population base in eastern and southern Asia 
might contribute to the mortality increase and the dominant mortality among all regions. 
From the population information from table 17 and 18, it can be said that population 
variance for Sub-Saharan Africa is hugely varied among different population scenarios. 
A highly-fragmented scenario would predict a much higher population in Sub-Saharan 
region in the future especially as Sub-Saharan would have higher population amount 
than eastern Asia in SSP3.  There is a substantial increase in Sub-Saharan Africa from 
2000 to 2030. The population normalized relative risk for COPD disease is not largely 
changed with the value at 1.04, so the population exposure to Saharan dust would 
increase due to population growth alone. 
It is calculate that there is 460,548,477(unit: person) estimated COPD mortality under 
SSP1, SSP2, SSP3 scenarios respectively at 2000 and 520,637,581(unit: person) 
estimated COPD mortality under SSP1, SSP2, SSP3 scenarios respectively at 2030 
under emission scenario RCP2.6. 
 
 
TABLE 15 COPD MORTALITY FROM GISS-E2-R OUTPUT UNDER POPULATION SCENARIO SSP1, SSP2 and 
SSP3 FOR THE TIME PERIOD OF 2000S  
region COPD mortality GISS-E2-R 2000 
Unit: person per year 
SSP1 SSP2 SSP3 
CIS 14.67 15.17 14.42 
developed countries 33.00 33.00 33.00 
Sub-Saharan Africa 26.25 26.25 37.33 
Eastern Asia 230.50 282.75 230.50 
Latin America and the Caribbean 20.17 20.17 20.17 
Northern Africa 6.67 6.67 9.17 
Oceania 0.42 0.42 0.42 
Southern Asia 95.08 124.92 95.08 
South-Eastern Asia 24.67 30.17 24.67 
Western Asia 8.50 8.50 11.75 
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TABLE 16 COPD MORTALITY FROM GISS-E2-R OUTPUT UNDER POPULATION SCENARIO SSP1, SSP2 AND 
SSP3 FOR THE TIME PERIOD OF 2030S UNDER THE RCP2.6 EMISSION SCENARIO 
region COPD mortality GISS-E2-R  
RCP2.6 2030 
Unit: person per year 
SSP1 SSP2 SSP3 
CIS 14.17 15.17 14.67 
developed countries 38.58 38.25 36.17 
Sub-Saharan Africa 48.08 50.92 76.50 
Eastern Asia 219.75 275.08 225.17 
Latin America and the 
Caribbean 24.50 25.42 26.75 
Northern Africa 8.92 9.25 13.42 
Oceania 0.58 0.58 0.67 
Southern Asia 123.33 172.92 135.83 
South-Eastern Asia 27.08 34.50 29.08 
Western Asia 14.58 15.33 22.58 
 
 
 
TABLE 17  POPULATION FOR VARIOUS REGIONS IN 2000 PREDICTED BY POPULATION SCENARIOS 
INCLUDING SSP1, SSP2 AND SSP3 
region population 2000 
Unit: million 
SSP1 SSP2 SSP3 
CIS 236.17 255.25 246 
developed countries 798.56 798.56 798.56 
Sub-Saharan Africa 443.73 443.73 619 
Eastern Asia 1049.39 1288.95 1049.39 
Latin America and the 
Caribbean 374.85 374.85 374.85 
Northern Africa 89.8 89.8 123.68 
Oceania 4.4 4.4 4.4 
Southern Asia 1048.04 1373.02 1048.4 
South-Eastern Asia 408.94 472.92 408.94 
Western Asia 99.32 99.32 138.07 
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TABLE 18 POPULATION FOR VARIOUS REGIONS IN 2030 PREDICTED BY POPULATION SCENARIOS 
INCLUDING SSP1, SSP2 AND SSP3 
region population 2030 
Unit: million 
SSP1 SSP2 SSP3 
CIS 243.43 285.96 283.18 
developed countries 912.29 904.42 854.74 
Sub-Saharan Africa 854.88 906.66 1351.49 
Eastern Asia 1053.63 1321.93 1080.27 
Latin America and the 
Caribbean 470.42 489 516.06 
Northern Africa 118.66 123.28 179.24 
Oceania 6.54 6.90 7.19 
Southern Asia 1433.07 2008.63 1580.92 
South-Eastern Asia 468.57 556.26 500.48 
Western Asia 175.68 183.88 271.93 
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CHAPTER FIVE 
CONCLUSION AND RECOMMENDATIONS 
 
This study illustrates the continuous data from pre-industrial times and the future.  
Integrated exposure–response (IER) functions are used rather than concentration-
response functions in light of global mortality assessment to reduce the uncertainty 
derived from health impact assessment function.  Black carbon adjusted PM2.5 
concentration is also applied to the health risk analysis.  There is comparison between 
various models, Representative Concentration Pathways and Socioeconomic pathways 
scenarios to assess the impact of various scenarios. 
For model comparison, NCAR-CAM3.5 has much lower prediction than other models 
and the population-normalized value are much lower for MIROC-CHEM model than the 
others.  Multi-model ensemble is conducted to integrate the output from various models. 
Ensemble results show that there is obvious increase from 1850 to 2000 in East Asia 
and Arabian Peninsula.  Variation related to various emission, population scenarios and 
regional distribution are extensively discussed in this paper. Seasonal and time series of 
relative risk variation are calculated and discussed in this paper as well. 
In further related study, it would be interesting to see into the mortality variation with 
more accurate baseline mortality data since the current available studies use country 
level baseline mortality data instead of state or county level, which can be problematic 
for the spatial analysis for large countries since the spatial distribution is going to be the 
same over all a large terrain.  Persistent peak of PM2.5 concentration and relative risk in 
northern Africa regions might be attributed to the Saharan dust storm contribution, 
which is also consistent with ensemble dust concentration output. Australia dust storm 
also contributes to the elevation of relative risk.  Eastern and south-eastern Asia would 
be dominant in mortality compared with other regions.  
There is a high increase (1.49%) in the lower respiratory infection relative risk for Latin 
America and Caribbean region. it might be reasonable to take the black carbon toxicity 
into consideration when addressing COPD mortality. 
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 Population normalized COPD premature mortality is calculated and compared in this 
paper.  There is 460,548,477 (unit: person) estimated COPD mortality under SSP1, 
SSP2, SSP3 scenarios respectively at 2000 and 520,637,581 (unit: person) at 2030 
under the emission scenario RCP2.6. The population exposure to Saharan dust would 
increase due to population growth alone. The relatively large population base in eastern 
and southern Asia might contribute to the mortality increase and the dominant mortality 
of Asia among all regions. 
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Figure 50 Global relative risk for lung cancer from January to June of the three year average data from 1850 to 1852 
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed 
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. 
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function 
from IER model for LNC disease endpoint. 
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Figure 51 Global relative risk for lung cancer from July to December of the three year average data from 1850 to 
1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 52 Global relative risk for lower respiratory infection disease from January to June of the three year average 
data from 1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated 
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal 
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 53 Global relative risk for cardiopulmonary disease from July to December of the three year average data from 
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 54 Global relative risk for cardiopulmonary disease from January to June of the three year average data from 
1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 55 Global relative risk for cardiopulmonary disease from July to December of the three year average data from 
1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 56 Global relative risk for lung cancer from January to June of the three year average data from 1860 to 1862 
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed 
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. 
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function 
from IER model for LNC disease endpoint. 
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Figure 57 Global relative risk for lung cancer from July to December of the three year average data from 1860 to 
1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 58 Global relative risk for lower respiratory infection disease from January to June of the three year average 
data from 1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated 
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal 
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 59 Global relative risk for lower respiratory infection disease from July to December of the three year average 
data from 1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated 
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal 
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 60 Global relative risk for cardiopulmonary disease from January to June of the three year average data from 
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 61 Global relative risk for cardiopulmonary disease from July to December of the three year average data from 
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 62 Global relative risk for lung cancer from January to June of the three year average data from 2000 to 2002 
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed 
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. 
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function 
from IER model for LNC disease endpoint. 
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Figure 63 Global relative risk for lung cancer from July to December of the three year average data from 2000 to 
2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 64 Global relative risk for lower respiratory infection from January to June of the three year average data from 
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 65 Global relative risk for lower respiratory infection from July to December of the three year average data 
from 2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint.
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Figure 66 Global relative risk for cardiopulmonary disease from January to June of the three year average data from 
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 67 Global relative risk for cardiopulmonary disease from July to December of the three year average data from 
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for COPD disease endpoint. 
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Figure 68 Global relative risk for lung cancer from January to June of the three year average data from 2030 to 2032 
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed 
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. 
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function 
from IER model for LNC disease endpoint. 
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Figure 69 Global relative risk for lung cancer from July to December of the three year average data from 2030 to 
2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 70 Global relative risk for lower respiratory infection from January to June of the three year average data from 
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 71 Global relative risk for lower respiratory infection from July to December of the three year average data 
from 2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 72 Global relative risk for lung cancer from January to June of the three year average data from 2050 to 2052 
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed 
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. 
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function 
from IER model for LNC disease endpoint. 
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Figure 73 Global relative risk for lung cancer from July to December of the three year average data from 2050 to 
2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function 
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate 
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-
risk function from IER model for LNC disease endpoint. 
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Figure 74 Global relative risk for lower respiratory infection from January to June of the three year average data from 
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 75 Global relative risk for lower respiratory infection from July to December of the three year average data 
from 2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk 
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes 
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the 
concentration-risk function from IER model for LRI disease endpoint. 
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Figure 76 Grid averaged LNC relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of 
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since 
pre-industrial times. 
 
 
 
Figure 77 Grid averaged LRI relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of 
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since 
pre-industrial times. 
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EPA environmental protection agency 
GBD global burden of disease 
IHD ischemic heart disease 
BenMAP-CE Environmental Benefits Mapping and Analysis Program - Community Edition 
C-R concentration-response 
ACCMIP Atmospheric Chemistry and Climate Model Intercomparison Project  
PM2.5  particle matter with aerodynamic diameter less than 2.5 micrometer 
PM10 particle matter with aerodynamic diameter less than 10 micrometer 
PM10-2.5  particle matter with aerodynamic diameter between 2.5 and 10 micrometer 
EC elemental carbon 
OC organic carbon 
CRFs concentration-response functions 
IER integrated exposure-response 
COPD chronic obstructive pulmonary disease 
YLDs Years lived with disability 
RR relative risk 
SAT Systematic Approach to Training 
WHO World Health Organization 
AOD aerosol optical depth 
BC black carbon 
OA organic aerosol 
SOA secondary organic aerosol 
SS sea slat 
SSP Shared Socio-economic Pathways 
LRI lower respiratory infection 
LNC lung cancer 
DC developed countries 
CIS Caucasus and Central Asia 
NA Northern Africa 
LAC Latin America and the Carribbean 
EA Eastern Asia 
SA Southern Asia 
SEA South-eastern Asia 
WA Western Asia 
O Oceania 
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